Comparison of inhaled and intravenous terbutaline in acute severe asthma.
AUTOR(ES)
Williams, S J
RESUMO
In patients with acute severe asthma, 5 mg of terbutaline by inhalation and 500 microgram intravenously in divided doses both produced equally effective but not maximal bronchodilatation. There was no difference in the production of side-effects. These results support the view that inhaled therapy can be as effective in patients with acute severe asthma as injected treatment. In view of the risks of intravenous treatment, especially using high doses, inhaled bronchodilator therapy would seem advisable as initial treatment.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=471658Documentos Relacionados
- Subcutaneous adrenaline versus terbutaline in the treatment of acute severe asthma.
- Intravenous or inhaled salbutamol in severe acute asthma?
- Controlled trial of intravenous corticosteroids in severe acute asthma.
- Metabolic effects of intravenous salbutamol in the course of acute severe asthma.
- Domiciliary comparison of terbutaline treatment by metered dose inhaler with and without conical spacer in severe and moderately severe chronic asthma.
